China venture capital

Cheaper entry valuations and ample exit options are reigniting Chinese VC activity

The Covid-19 pandemic is pushing renewed interest into healthcare sectors, where VC’s are looking for investments that not only survive but thrive under these unpredictable conditions.

Despite a pickup of activity in March, venture capital (VC) financing fell by more than half to $3.8 billion during the first quarter of 2020 compared to the same period last year, according to the Asian Venture Capital Journal. With investors unable to travel or channel check companies, most activity was understandably put on hold.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media